VRTX — VERTEX PHARMACEUTICALS INCORPORATED CMN

Ownership history in FORA Capital, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which FORA Capital, LLC reported a position in VERTEX PHARMACEUTICALS INCORPORATED CMN (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.51% (2024 Q3)
Avg. % of fund
0.32%
First filed
2019 Q4
Last filed
2025 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,168 -6,234 -66.3% 0.22% $1.2M $391.64
2024 Q3 ADDED 9,402 +1,229 +15.0% 0.51% $4.4M $465.08
2024 Q2 ADDED 8,173 +3,329 +68.7% 0.47% $3.8M $468.72
2024 Q1 REDUCED 4,844 -10,345 -68.1% 0.17% $2.0M $418.01
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%
← Back to FORA Capital, LLC Holdings